Borders should no longer be barriers: The EU-X-CT Multi-stakeholder Initiative

To support patient communities, investigators, and trial sponsors in enabling cross-border access to clinical trials when appropriate, EFGCP and EFPIA have set up a multi-stakeholder consortium of patient organisations, academia, research networks and industry with the aim to develop recommendations to enable cross-border access to clinical trials for patients across the EU.

With no current European Framework to define the conditions for cross border clinical trials, the project will map out the current state of each Member State, detailing the logistical and financial support required as well as issues like accessing ongoing treatment for those patients involved. The project will be vital in bringing groundbreaking trials to patients in countries who previously had no access and could revolutionise treatment options for those with rare diseases.

Read the full press release here